Looking beyond the spin of Big Pharma PR. But encouraging gossip. Come in and confide, you know you want to! “I’ll publish right or wrong. Fools are my theme, let satire be my song.”
Tuesday, February 21, 2012
Finally! Johnson & Johnson CEO Steps Down After Product Recalls - - CNBC
Johnson & Johnson CEO Bill Weldon is retiring in April following an embarrassing string of product recalls that has stretched for more than two years, costing the health-care giant hundreds of millions of dollars and consumer trust.
Vice Chairman Alex Gorsky, 51, will become CEO effective April 26, the date of J&;J's next board meeting, the company said. Gorsky was also nominated to the board, it added. Weldon, 63, remains the chairman.